Pharma’s Secret Middlemen
samedi 16 mars 2024 à 07:51"Pharmacy benefit managers", companies that act as middlemen in insurance payments for medicines in the US, by making demands that harm patients.
The biggest spend tens of millions of dollars stopping Congress from fixing the problem.
The three biggest of them are owned by giant companies that they have to work with — one is owned by a pharmacy chain, and two by insurance companies. This creates a conflict of interest. In addition to the reforms proposed, such connections should be specifically prohibited.